← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2014Last known activity
Sep 15, 2021
Timeline
2010s
- Jan 1, 2014
A2 Healthcare Taiwan Corporation— Founded
Drugs by trial phase (12 distinct, 11 trials)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Alopecia
- Alopecia Areata
- Alzheimer Disease
- Carcinoma
- Carcinoma, Hepatocellular
- Dementia
- Dementia, Vascular
- Diabetes Mellitus
- Diabetic Foot
- Erectile Dysfunction
- Fibrosis
- Foot Ulcer
- Hepatitis B
- Hepatitis B, Chronic
- Kidney Diseases
- Liver Cirrhosis
- Melanoma
- Osteoarthritis
- Osteoarthritis, Knee
- Renal Insufficiency, Chronic
- Ulcer
Recent trials (11)
- NCT05027581CollaboratorPhase 2Sep 15, 2021
- NCT03351322CollaboratorPhase 2May 23, 2018
- NCT03256331CollaboratorPhase 1Jun 21, 2017
- NCT03102398CollaboratorPhase 1/Phase 2May 8, 2017
- NCT02994498Lead sponsorPhase 1/Phase 2Mar 1, 2017
- NCT02467413CollaboratorPhase 2Mar 1, 2017
- NCT02933827CollaboratorPhase 1/Phase 2Dec 1, 2016
- NCT02737748CollaboratorPhase 1/Phase 2Jul 1, 2016
- NCT02672436CollaboratorPhase 2Jun 1, 2016
- NCT02784964CollaboratorPhase 1/Phase 2Mar 1, 2016
- NCT02289300Lead sponsorPhase 2Dec 1, 2014
Details
- Founded
- Tokyo, JP Jan 1, 2014
- Last known activity
- Sep 15, 2021